Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Cardiology/Vascular Diseases
Disease Category: Atrial Fibrillation
Location: United States, TX

Clinical Trial Details

Overview

Research Study Summary

Atrial Fibrillation - Houston, TX

Purpose

The primary objective of this study is to determine if apixaban is noninferior to warfarin in the endpoint of stroke and systemic embolism in individuals with AF

Patient Inclusion Criteria: Must be at least 18 years of age or older and have atrial fibrillation or atrial flutter

Patient Exclusion Criteria: Can not have atrial fibrillation or flutter due to reversible causes (ie thyrotoxicosis, pericarditis). Can not have clinically significant mitral stenosis. Can not have persistent and uncontrolled hypertension.

To Learn more
Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Marianne Tadros, Clinical Team Lead
DM Clinical Research
12345 Jones Road, Suite 295
Houston, TX 77070
Phone: 281-517-0550
Fax: 281-946-8363

View Map

Research Center Information: DM Clinical Research

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 155652

Date Last Changed: July 24, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.